tiprankstipranks
Trending News
More News >
Valerio Therapeutics (FR:ALVIO)
:ALVIO
France Market

Valerio Therapeutics (ALVIO) Income Statement

Compare
0 Followers

Valerio Therapeutics Income Statement

Last quarter (Q2 2024), Valerio Therapeutics's total revenue was €89.00K, an increase of Infinity% from the same quarter last year. In Q2, Valerio Therapeutics's net income was €-10.96M. See Valerio Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
€ 1.80M€ 1.44M€ 4.06M€ 1.78M€ 4.29M
Gross Profit
€ 1.27M€ 929.00K€ 3.69M€ -166.00K€ 3.94M
Operating Expenses
€ 21.55M€ 18.04M€ 9.26M€ 9.24M€ 19.73M
Depreciation and Amortization
€ 1.74M€ 33.00K€ 511.00K€ 654.00K€ 698.00K
EBITDA
€ -18.44M€ -17.04M€ -4.90M€ 2.33M€ -35.66M
Operating Income
€ -20.29M€ -17.11M€ -5.58M€ -7.81M€ -9.79M
Other Income/Expenses
€ -39.00K€ -2.55M€ -1.52M€ -348.00K€ -26.26M
Pretax Income
€ -20.33M€ -19.27M€ -6.66M€ 1.85M€ -36.05M
Net Income
€ -20.34M€ -19.56M€ -5.94M€ 1.09M€ -33.73M
Per Share Metrics
Basic EPS
€ -0.15€ -0.18€ -0.07€ 0.01€ -0.55
Diluted EPS
€ -0.15€ -0.18€ -0.07€ 0.01€ -0.55
Weighted Average Shares Outstanding
135.63M 105.75M 88.21M 73.15M 61.38M
Weighted Average Shares Outstanding (Diluted)
135.63M 105.75M 88.21M 75.87M 61.38M
Currency in EUR

Valerio Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis